Deans' stroke musings: Psilocybin Microdosing Promising for Mental Health Disorders

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Wednesday, October 11, 2023

Psilocybin Microdosing Promising for Mental Health Disorders

But hasn't your doctor already prescribed psilocybin for your stroke recovery? WHY NOT? They are that fucking incompetent?

psilocybin (26 posts to May 2014)

Psilocybin Microdosing Promising for Mental Health Disorders

Summary: Researchers delve into the therapeutic potential of psilocybin microdosing, exploring its influence on stress resilience and compulsive behaviors in rats.

While high-dose psilocybin therapy has been scrutinized for psychiatric treatment applications, this study focuses on low, repeated doses—commonly known as ‘microdosing’—and its burgeoning popularity in self-medication narratives online.

Findings reveal not only a tolerance for the psychedelic substance but an increased resilience to stress and a reduction in compulsive behaviors among the rodent subjects.

Moreover, enhanced connectivity to the brain’s thalamus, implicated in decision-making and concern filtration, hints at why numerous anecdotal reports laud the positive wellbeing effects of psychedelic mushrooms.

Key Facts

Enhanced Stress Resilience: Rats exposed to repeated low doses of psilocybin demonstrated increased resilience to stress and exhibited fewer compulsive behaviors.
Brain Connectivity: A notable surge in connections to the thalamus, a critical brain region for decision-making and concerns filtering, was observed in rats post psilocybin microdosing.(Sounds good for stroke recovery.)
Global Traction: The phenomenon of microdosing is garnering global attention with several countries either legalizing or moving toward the legalization of psilocybin for therapeutic interventions.

Source: University of Southern Denmark

A new research result from the University of Southern Denmark opens the door to the possibility of using psilocybin, the active compound in mushrooms with psychedelic properties, as a therapeutic tool through microdosing.

Psilocybin has long been recognized as a classic psychedelic substance and has recently been investigated for its potential to assist in the treatment of various psychiatric disorders, primarily depression and addiction, through therapy supplemented with a high dose of psilocybin.